Intestinal disorders in these affected individuals likely stem from GC-C/cGMP-enhanced ion movement and include inflammatory bowel disease (specifically Crohn’s disease), intestinal obstruction associated with volvulus, and infectious gastroenteritis. Here, GUCY2C is linked to intestinal disorder.